BRD2 and obesity due to melanocortin 4 receptor deficiency: Although these studies suggest obesity as a potential mediator of the relationship between FSH and cardiometabolic disease, findings about the effects of FSH on cardiometabolic risk in post-menopausal women are inconsistent, and the pathophysiology that underlie this association is not well determined yet.